475272-74-3

Basic information

• Product Name: Methyl 5-{[(5-amino-6-(benzyloxy)-2-pyridinyl)carbonyl]amino}-6-isopropoxy-2-pyridinecarboxylate
• Synonyms: Methyl 5-{[(5-amino-6-(benzyloxy)-2-pyridinyl)carbonyl]amino}-6-isopropoxy-2-pyridinecarboxylate
• CAS NO: 475272-74-3
• Molecular Weight: 436.467
• Mol File: 475272-74-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Methyl 5-{[(5-amino-6-(benzyloxy)-2-pyridinyl)carbonyl]amino}-6-isopropoxy-2-pyridinecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 5-{[(5-amino-6-(benzyloxy)-2-pyridinyl)carbonyl]amino}-6-isopropoxy-2-pyridinecarboxylate(475272-74-3)
• EPA Substance Registry System: Methyl 5-{[(5-amino-6-(benzyloxy)-2-pyridinyl)carbonyl]amino}-6-isopropoxy-2-pyridinecarboxylate(475272-74-3)

Safety Data

• Hazardous Substances Data: 475272-74-3(Hazardous Substances Data)

Upstream product

• 475272-83-4 5-[(6-benzyloxy-5-nitro-pyridine-2-carbonyl)-amino]-6-isopropoxy-pyridine-2-carboxylic acid methyl ester 
• 475272-63-0 5-nitro-6-phenylmethoxypyridine-2-carboxylic acid 
• 353293-50-2 2-(Benzyloxy)-6-chloro-3-nitropyridine 
• 475272-66-3 Methyl 6-isopropoxy-5-nitro-2-pyridinecarboxylate 
• 475272-69-6 methyl 5-amino-6-isopropoxypicolinate 
• 186413-90-1 6-isopropoxy-5-nitropyridine-2-carboxylic acid 
• 186413-80-9 2-isopropoxy-3-nitro-6-vinylpyridine 
• 186413-77-4 6-chloro-3-nitro-2-(propan-2-yloxy)pyridine 
• 92138-35-7 6-chloro-3-nitro-1H-pyridin-2-one 
• 16013-85-7 2,6-dicholoro-3-nitropyridine 

Downstream Products

• 475272-87-8 Methyl 5-{[(6-(benzyloxy)-5-{[(6-isopropoxy-5-nitro-2-pyridinyl)carbonyl]amino}-2-pyridinyl)carbonyl]amino}-6-isopropoxy-2-pyridine carboxylate 

Relevant articles and documents

Proteomimetic compounds and methods

The present invention relates to compounds and pharmaceutical compositions which are proteomimetic and to methods for inhibiting the interaction of an alpha-helical protein with another protein or binding site. Methods for treating diseases or conditions which are modulated through interactions between alpha helical proteins and their binding sites are other aspects of the invention.